Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FQJFQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,673
Award facts
- Contract value 100% obligated
- $24,672.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $24,672.52 delivery order on August 28, 2025, for the supply of Dupixent 300 mg/2 ml syringes. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 29, 2025, and performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated capability to meet federal procurement requirements through competitive award processes. The company serves as a critical vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, supplying specialty medications, brand-name and generic drugs, vaccines, syringes, and medical supplies across multiple therapeutic domains. This delivery order represents a routine transaction within the broader pharmaceutical support framework that positions AmerisourceBergen to participate in the Defense Logistics Agency's planned Pharmaceutical Prime Vendor Global Program Generation V contracts.
Quick answers
Who was awarded contract SPE2DB25FQJFQ?
SPE2DB25FQJFQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 28, 2025.
How much is contract SPE2DB25FQJFQ worth?
The government has obligated $24,673 on SPE2DB25FQJFQ.
Is contract SPE2DB25FQJFQ an order under another contract?
Yes. SPE2DB25FQJFQ is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQJFQ competed?
The extent of competition for SPE2DB25FQJFQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award